- Scope of the procurement
- i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West
- ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England
- iii) Lot 3 - London comprising the NHS England Region: London
- iv) Lot 4 - the South: comprising the South East and the South West
Section one: Contracting authority
one.1) Name and addresses
NHS England - Specialised Commissioning
80 London Road
London
SE1 6LH
Contact
Josselin Canevet
Country
United Kingdom
Region code
UK - United Kingdom
Internet address(es)
Main address
Buyer's address
https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/68205
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://uk.eu-supply.com/login.asp?B=agcsu
Additional information can be obtained from the above-mentioned address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Total pancreatectomy with islet autotransplantation (TPIAT) service
Reference number
62207
two.1.2) Main CPV code
- 85000000 - Health and social work services
two.1.3) Type of contract
Services
two.1.4) Short description
NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England Highly Specialised Services (referred to as the Commissioner), is undertaking a market engagement exercise to understand the current and future capacity and capability of providers and potential providers within this highly specialised area. All interested parties, including incumbent providers, are encouraged to register their interest and participate in the market engagement questionnaire which will provide feedback to commissioners. Please note that this is not a call for competition although the commissioner would encourage all potential providers to respond to this market engagement exercise. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered to inform the commissioning approach.
two.1.5) Estimated total value
Value excluding VAT: £11,328,000
two.1.6) Information about lots
This contract is divided into lots: Yes
two.2) Description
two.2.1) Title
i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West
Lot No
1
two.2.2) Additional CPV code(s)
- 85000000 - Health and social work services
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKE - Yorkshire and the Humber
- UKD - North West (England)
- UKC - North East (England)
two.2.4) Description of the procurement
This market engagement exercise is to re-commission a service for the provision of the Total pancreatectomy with islet autotransplantation (TPIAT) service from April 2023.
NHS England is looking to re-commission TPIAT services for adult patients with hereditary chronic pancreatitis and who are at high risk of developing pancreatic cancer and for patients with acquired intractable chronic pancreatitis who meet specific clinical criteria
The primary goal of surgery is to remove the cause of the symptoms i.e. the pancreas (total pancreatectomy) with an aim to control pain resistant to other therapies; islet auto transplantation (a procedure where the patient’s own islets are isolated and infused into their liver) is intended to prevent or lessen the very brittle (hard to control) diabetes mellitus which is an inevitable result of total pancreatectomy.
We would like to receive responses from incumbent and potential provider(s) who are able to meet all of the following key criteria:
a) Expertise in the assessment and management of patients with chronic pancreatitis;
b) Access to a specialist pain management service;
c) Experience of pancreatic surgery and expertise in the management of patients who have undergone total pancreatectomy;
d) Experience of islet transplantation including an on-site islet isolation laboratory licenced by the Human Tissue Authority conforming to Good Manufacturing Practice;
e) Having in place a specialist team with expertise in the management of complex Type 1 diabetes mellitus, including the full range of therapeutic options (including insulin pumps and psychological assessment) and expertise;
• (The above criteria may be evidenced for example by, number and range of patients on caseload, multi-disciplinary team experienced in the care of patients with chronic pancreatitis, published research papers)
f) Having in place information governance processes that permit the collection of the specified clinical outcome data;
g) Experience of engaging positively with associated patient support groups.
The services will be provided in four centres (one per defined geographical catchment area) which provide a high volume Hepato-pancreatobiliary service with significant experience in managing severe chronic pancreatitis, carrying out pancreatectomy; undertaking islet cell transplantation and having in place an appropriate multi-disciplinary team.
Incumbent providers are required to respond to this market engagement exercise along with any prospective providers who can meet the service requirements.
The Lots will be as follows:
i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West,
ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England
iii) Lot 3 - London comprising the NHS England Region: London
iv) Lot 4 - the South: comprising the South East and the South West
The questionnaire is available through the EU Supply portal: https://uk.eu-supply.com/login.asp?B=agcsu
The reference is 62207 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 20th December 2022.
Applications may be made jointly where partners can demonstrate appropriate expertise and meet the service criteria set out in the questionnaire and referenced documents.
The anticipated contract period is 3 years.
The commissioner reserves the right to direct award where competition is absent.
The existing contracts are due to expire on 31st March 2023 and the Commissioner is running this market engagement exercise to ascertain whether there is competition in the market and to help inform future commissioning plans.
This notice is to advise incumbent and prospective providers in the market of the commissioner’s intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire.
two.2.14) Additional information
The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach.
two.2) Description
two.2.1) Title
ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England
Lot No
2
two.2.2) Additional CPV code(s)
- 85000000 - Health and social work services
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKH - East of England
- UKG - West Midlands (England)
- UKF - East Midlands (England)
two.2.4) Description of the procurement
This market engagement exercise is to re-commission a service for the provision of the Total pancreatectomy with islet autotransplantation (TPIAT) service from April 2023.
NHS England is looking to re-commission TPIAT services for adult patients with hereditary chronic pancreatitis and who are at high risk of developing pancreatic cancer and for patients with acquired intractable chronic pancreatitis who meet specific clinical criteria
The primary goal of surgery is to remove the cause of the symptoms i.e. the pancreas (total pancreatectomy) with an aim to control pain resistant to other therapies; islet auto transplantation (a procedure where the patient’s own islets are isolated and infused into their liver) is intended to prevent or lessen the very brittle (hard to control) diabetes mellitus which is an inevitable result of total pancreatectomy.
We would like to receive responses from incumbent and potential provider(s) who are able to meet all of the following key criteria:
a) Expertise in the assessment and management of patients with chronic pancreatitis;
b) Access to a specialist pain management service;
c) Experience of pancreatic surgery and expertise in the management of patients who have undergone total pancreatectomy;
d) Experience of islet transplantation including an on-site islet isolation laboratory licenced by the Human Tissue Authority conforming to Good Manufacturing Practice;
e) Having in place a specialist team with expertise in the management of complex Type 1 diabetes mellitus, including the full range of therapeutic options (including insulin pumps and psychological assessment) and expertise;
• (The above criteria may be evidenced for example by, number and range of patients on caseload, multi-disciplinary team experienced in the care of patients with chronic pancreatitis, published research papers)
f) Having in place information governance processes that permit the collection of the specified clinical outcome data;
g) Experience of engaging positively with associated patient support groups.
The services will be provided in four centres (one per defined geographical catchment area) which provide a high volume Hepato-pancreatobiliary service with significant experience in managing severe chronic pancreatitis, carrying out pancreatectomy; undertaking islet cell transplantation and having in place an appropriate multi-disciplinary team.
Incumbent providers are required to respond to this market engagement exercise along with any prospective providers who can meet the service requirements.
The Lots will be as follows:
i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West,
ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England
iii) Lot 3 - London comprising the NHS England Region: London
iv) Lot 4 - the South: comprising the South East and the South West
The questionnaire is available through the EU Supply portal: https://uk.eu-supply.com/login.asp?B=agcsu
The reference is 62207 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 20th December 2022.
Applications may be made jointly where partners can demonstrate appropriate expertise and meet the service criteria set out in the questionnaire and referenced documents.
The anticipated contract period is 3 years.
The commissioner reserves the right to direct award where competition is absent.
The existing contracts are due to expire on 31st March 2023 and the Commissioner is running this market engagement exercise to ascertain whether there is competition in the market and to help inform future commissioning plans.
This notice is to advise incumbent and prospective providers in the market of the commissioner’s intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire.
two.2.14) Additional information
The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach.
two.2) Description
two.2.1) Title
iii) Lot 3 - London comprising the NHS England Region: London
Lot No
3
two.2.2) Additional CPV code(s)
- 85000000 - Health and social work services
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKI - London
two.2.4) Description of the procurement
This market engagement exercise is to re-commission a service for the provision of the Total pancreatectomy with islet autotransplantation (TPIAT) service from April 2023.
NHS England is looking to re-commission TPIAT services for adult patients with hereditary chronic pancreatitis and who are at high risk of developing pancreatic cancer and for patients with acquired intractable chronic pancreatitis who meet specific clinical criteria
The primary goal of surgery is to remove the cause of the symptoms i.e. the pancreas (total pancreatectomy) with an aim to control pain resistant to other therapies; islet auto transplantation (a procedure where the patient’s own islets are isolated and infused into their liver) is intended to prevent or lessen the very brittle (hard to control) diabetes mellitus which is an inevitable result of total pancreatectomy.
We would like to receive responses from incumbent and potential provider(s) who are able to meet all of the following key criteria:
a) Expertise in the assessment and management of patients with chronic pancreatitis;
b) Access to a specialist pain management service;
c) Experience of pancreatic surgery and expertise in the management of patients who have undergone total pancreatectomy;
d) Experience of islet transplantation including an on-site islet isolation laboratory licenced by the Human Tissue Authority conforming to Good Manufacturing Practice;
e) Having in place a specialist team with expertise in the management of complex Type 1 diabetes mellitus, including the full range of therapeutic options (including insulin pumps and psychological assessment) and expertise;
• (The above criteria may be evidenced for example by, number and range of patients on caseload, multi-disciplinary team experienced in the care of patients with chronic pancreatitis, published research papers)
f) Having in place information governance processes that permit the collection of the specified clinical outcome data;
g) Experience of engaging positively with associated patient support groups.
The services will be provided in four centres (one per defined geographical catchment area) which provide a high volume Hepato-pancreatobiliary service with significant experience in managing severe chronic pancreatitis, carrying out pancreatectomy; undertaking islet cell transplantation and having in place an appropriate multi-disciplinary team.
Incumbent providers are required to respond to this market engagement exercise along with any prospective providers who can meet the service requirements.
The Lots will be as follows:
i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West,
ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England
iii) Lot 3 - London comprising the NHS England Region: London
iv) Lot 4 - the South: comprising the South East and the South West
The questionnaire is available through the EU Supply portal: https://uk.eu-supply.com/login.asp?B=agcsu
The reference is 62207 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 20th December 2022.
Applications may be made jointly where partners can demonstrate appropriate expertise and meet the service criteria set out in the questionnaire and referenced documents.
The anticipated contract period is 3 years.
The commissioner reserves the right to direct award where competition is absent.
The existing contracts are due to expire on 31st March 2023 and the Commissioner is running this market engagement exercise to ascertain whether there is competition in the market and to help inform future commissioning plans.
This notice is to advise incumbent and prospective providers in the market of the commissioner’s intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire.
two.2.14) Additional information
The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach.
two.2) Description
two.2.1) Title
iv) Lot 4 - the South: comprising the South East and the South West
Lot No
4
two.2.2) Additional CPV code(s)
- 85000000 - Health and social work services
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKK - South West (England)
- UKJ - South East (England)
two.2.4) Description of the procurement
This market engagement exercise is to re-commission a service for the provision of the Total pancreatectomy with islet autotransplantation (TPIAT) service from April 2023.
NHS England is looking to re-commission TPIAT services for adult patients with hereditary chronic pancreatitis and who are at high risk of developing pancreatic cancer and for patients with acquired intractable chronic pancreatitis who meet specific clinical criteria
The primary goal of surgery is to remove the cause of the symptoms i.e. the pancreas (total pancreatectomy) with an aim to control pain resistant to other therapies; islet auto transplantation (a procedure where the patient’s own islets are isolated and infused into their liver) is intended to prevent or lessen the very brittle (hard to control) diabetes mellitus which is an inevitable result of total pancreatectomy.
We would like to receive responses from incumbent and potential provider(s) who are able to meet all of the following key criteria:
a) Expertise in the assessment and management of patients with chronic pancreatitis;
b) Access to a specialist pain management service;
c) Experience of pancreatic surgery and expertise in the management of patients who have undergone total pancreatectomy;
d) Experience of islet transplantation including an on-site islet isolation laboratory licenced by the Human Tissue Authority conforming to Good Manufacturing Practice;
e) Having in place a specialist team with expertise in the management of complex Type 1 diabetes mellitus, including the full range of therapeutic options (including insulin pumps and psychological assessment) and expertise;
• (The above criteria may be evidenced for example by, number and range of patients on caseload, multi-disciplinary team experienced in the care of patients with chronic pancreatitis, published research papers)
f) Having in place information governance processes that permit the collection of the specified clinical outcome data;
g) Experience of engaging positively with associated patient support groups.
The services will be provided in four centres (one per defined geographical catchment area) which provide a high volume Hepato-pancreatobiliary service with significant experience in managing severe chronic pancreatitis, carrying out pancreatectomy; undertaking islet cell transplantation and having in place an appropriate multi-disciplinary team.
Incumbent providers are required to respond to this market engagement exercise along with any prospective providers who can meet the service requirements.
The Lots will be as follows:
i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West,
ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England
iii) Lot 3 - London comprising the NHS England Region: London
iv) Lot 4 - the South: comprising the South East and the South West
The questionnaire is available through the EU Supply portal: https://uk.eu-supply.com/login.asp?B=agcsu
The reference is 62207 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 20th December 2022.
Applications may be made jointly where partners can demonstrate appropriate expertise and meet the service criteria set out in the questionnaire and referenced documents.
The anticipated contract period is 3 years.
The commissioner reserves the right to direct award where competition is absent.
The existing contracts are due to expire on 31st March 2023 and the Commissioner is running this market engagement exercise to ascertain whether there is competition in the market and to help inform future commissioning plans.
This notice is to advise incumbent and prospective providers in the market of the commissioner’s intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire.
two.2.14) Additional information
The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach.
two.3) Estimated date of publication of contract notice
30 January 2023
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes